Are AwardCue signals proof that a company wants a regulatory consultant?

No. A fresh award and project-specific regulatory language create a reason to research. They do not prove buyer intent, and the current pathway must be verified before outreach.

Where does the funding data come from?

AwardCue uses official NIH RePORTER and SBIR.gov records and keeps a source link with every released signal.

SBIR leads for FDA regulatory consultants

Find newly funded medtech and biotech companies with real regulatory milestones.

AwardCue turns current NIH and SBIR.gov awards into independently reviewed, source-linked briefs for boutique FDA regulatory firms. You see the funding event, the project-specific why-now cue, and what still needs verification.

Get five matched signals ↗Inspect the public sample

No card. No sales call. Plans start at $249/month only after you approve the sample.

EXAMPLE · NIH/NICHD · SBIR PHASE II

Non-hormonal contraceptive device with an IDE submission target

$1.10MCambridge, MAOfficial NIH record

Why now

The funded project names an IDE milestone. Classification, submission planning, and current agency alignment still require confirmation.

A research signal, not a claim that the company is shopping for services.

Open the official record ↗

≤30 daysaward freshness

100%official links

3-passindependent review

0quota filler

Filter for the engagement you sell

Fresh funding matters only when the project fits your regulatory lane.

AwardCue gates on timing, phase, disclosed amount, product language, geography, and the evidence in the official award. Generic health references do not pass as regulatory fit.

Devices and diagnostics

IDE, 510(k), De Novo, intended-use, analytical-validation, and clinical-study language.

Therapeutics and biologics

IND, preclinical, CMC, formulation, manufacturing, and agency-interaction milestones.

Quality and scale-up

Validation, manufacturing readiness, design controls, and funded transition work.

What reaches your inbox

Enough context to decide whether the account deserves research.

Each released signal includes company, award amount, program and phase, project title, bounded service cues, explicit caveats, public-contact provenance, and the official record. Unsafe or stale direct details are withheld.

Review the full five-lead brief

01
Official event
Trace the amount, date, agency, phase, and project scope to its source.
02
Why-now hypothesis
See the exact project language that may create regulatory work.
03
Contact-safety status
Know whether public details are current-looking, historical, withheld, or absent.

The honest boundary

Funding is evidence of activity. It is not evidence of intent to buy.

AwardCue narrows the research queue; it does not manufacture urgency. Your team verifies the present product, pathway, contact role, and outreach fit before making contact.

A current brief for your exact market

Judge five signals before you spend a dollar.

FDA / regulatory strategy is already selected. Add your territory and minimum award size.